Vet Pathol Download to Citation Manager
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beam, S. L.
Right arrow Articles by McDonough, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beam, S. L.
Right arrow Articles by McDonough, S. P.
Vet Pathol 40:496-500 (2003)
© 2003 American College of Veterinary Pathologists

An Immunohistochemical Study of Cyclooxygenase-2 Expression in Various Feline Neoplasms

S. L. Beam, K. M. Rassnick, A. S. Moore and S. P. McDonough

Department of Biomedical Sciences (SLB, SPM) and Department of Clinical Sciences (KMR), College of Veterinary Medicine, Cornell University, Ithaca, NY; and Harrington Oncology Program, School of Veterinary Medicine, Tufts University, North Grafton, MA (ASM)

Cyclooxygenase (COX) enzymes catalyze the synthesis of prostaglandins and exist as two isoforms, COX-1 and COX-2. COX-2 is a potent inducible mediator of inflammation. COX-2 is also upregulated in several human tumors and in canine squamous cell, renal cell, and transitional cell carcinomas, prostatic adenocarcinoma, and intestinal neoplasia. The purpose of this study was to determine whether COX-2 is expressed in various feline tumors. Results of this study may help determine whether COX-2 is a potential target for therapeutic and preventive strategies in cats. Immunohistochemical studies were performed on paraffin-embedded tissues using the amplified streptavidin–biotin–horseradish peroxidase system. COX-2 was found in 7 of 19 (37%) feline transitional cell carcinomas and in 2 of 21 (9%) feline oral squamous cell carcinomas. No COX-2 immunoreactivity was detected in cutaneous squamous cell carcinomas (6), adenocarcinomas (nine mammary, eight pulmonary, seven intestinal), lymphomas (six nasal, six intestinal), or 10 vaccine-associated sarcomas. The widespread absence of COX-2 expression in most feline neoplasms might suggest that COX-2 inhibitors would have a low potential as anticancer agents.

Key words: Cancer; cats; immunohistochemistry; squamous cell carcinoma; transitional cell carcinoma.

Request for reprints from Dr. K. M. Rassnick, Department of Clinical Sciences, Box 31, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853 (USA). E-mail: kmr32{at}cornell.edu.




This article has been cited by other articles:


Home page
 Vet Rec.Home page
S. Boonsoda and P. Wanikiat
Possible role of cyclooxygenase-2 inhibitors as anticancer agents
Vet Rec., February 2, 2008; 162(5): 159 - 161.
[Full Text] [PDF]

Home page
 jvdiHome page
K. M. Rassnick and B. L. Njaa
Cyclooxygenase-2 immunoreactivity in equine ocular squamous-cell carcinoma
J Vet Diagn Invest, July 1, 2007; 19(4): 436 - 439.
[Abstract] [Full Text] [PDF]

Home page
 jvdiHome page
S. J. Newman and L. Mrkonjich
Cyclooxygenase-2 expression in feline pancreatic adenocarcinomas
J Vet Diagn Invest, November 1, 2006; 18(6): 590 - 593.
[Abstract] [Full Text] [PDF]

Home page
 Vet PatholHome page
J. A. Landolfi and K. A. Terio
Transitional Cell Carcinoma in Fishing Cats (Prionailurus viverrinus): Pathology and Expression of Cyclooxygenase-1, -2, and p53.
Vet. Pathol., September 1, 2006; 43(5): 674 - 681.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American College of Veterinary Pathologists.